Abstract
Neuropeptide Y is distributed abundantly not only in the brain, but also in the gastrointestinal tract and suppresses intestinal muscle contraction in isolated muscle preparations. The purpose of the present study was to determine whether centrally administered neuropeptide Y modulated gastric emptying and intestinal transit in conscious rats. Graded doses of neuropeptide Y were administered intracisternally 1 min before ingestion of test meals through an oral tube. Four hours after ingestion of 60 Amberlite pellets, the rats were sacrificed and residual pellets in the stomach and the small intestine segments were counted to calculate the solid meal transit rate. The liquid meal transit rate was calculated 1 hr after 0.07% phenol red ingestion by determining the residual phenol red in the stomach and the small intestine segments. Neuropeptide Y elicited potent suppression of gastric emptying and intestinal transit of both solid and liquid meals. Pretreatment with propranolol antagonized, whereas phentolamine did not affect, the suppressive effect of central neuropeptide Y. Although carbachol blocked the effects of neuropeptide Y, neither atropine nor hexamethonium altered the actions of neuropeptide Y. In conclusions, centrally administered neuropeptide Y strongly inhibited gastrointestinal transit by stimulating a beta-adrenergic pathway.
Similar content being viewed by others
References
Tatemoto K, Carlquist M, Mutt V: Neuropeptide Y—a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296:659–660, 1982
De Quidt ME, Emson PC: Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system-2. Immunohistochemical analysis. Neuroscience 18:545–618, 1986
Chronwall BM, DiMaggio DA, Massari VJ, Pickel VM, Ruggiero DA, O'Donohue TL: The anatomy of neuropeptide-Y-containing neurons in rat brain. Neuroscience 15:1159–1181, 1985
Gray ST, Morley JE: Neuropeptide Y: anatomic distribution and possible function in mammalian nervous system. Life Sci 38:389–401, 1986
Stanley BG, Leibowitz SF: NPY: Stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci 35:2635–2642, 1984
Heilig M, Murison R: Intracerebroventricular neuropeptide Y suppresses open field and home cage activity in the rat. Regul Pept 19:221–231, 1987
Fuxe K, Agnati LF, Härfstrand A, Zini I, Tatemoto K, Pich EM, Hökfelt T, Mutt V, Terenius L: Central administration of NPY induces hypotension, bradypnea and EEG synchronization in the rat. Acta Physiol Scand 118:189–192, 1983
Matsuda M, Aono M, Moriga M, Okuma M: Centrally administered NPY stimulated gastric acid and pepsin secretion by a vagally mediated mechanism. Regul Pept 35:31–41, 1991
Ekblad E, Wahlestedt C, Ekelund M, Håkanson R, Sundler F: Neuropeptide Y in the gut and pancreas: Distribution and possible vasomotor function. Front Horm Res 12:85–90, 1984
Allen JM, Hughes J, Bloom SR: Presence, distribution, and pharmacological effects of neuropeptide Y in mammalian gastrointestinal tract. Dig Dis Sci 32:506–512, 1987
Ekblad E, Ekelund M, Graffner H, Håkanson R, Sundler F: Peptide-containing nerve fibers in the stomach wall of rat and mouse. Gastroenterology 89:73–85, 1985
Wang YN, McDonald JK, Wyatt RJ: Immunocytochemical localization of neuropeptide Y-like immunoreactivity in adrenergic and non-adrenergic neurons of the rat gastrointestinal tract. Peptides 8:145–151, 1987
Koch TR, Roddy DR, Carney JA, Telander RL, Go VLW: Distribution, quantitation, and origin of immunoreactive neuropeptide Y in the human gastrointestinal tract. Regul Pept 21:309–319, 1988
Reynell PC, Spray GH: The simultaneous measurement of absorption and transit in the gastrointestinal tract of the rat. J Physiol 131:452–462, 1956
Garzon J, Höllt V, Bláquez PS: Neuropeptide Y is an inhibitor of neural function in the myenteric plexus of the guinea-pig ileum. Peptides 7:623–629, 1986
Holzer P, Lippe ITH, Barth L, Saria A: NPY inhibits excitatory enteric neurons supplying the circular muscle of the guinea pig small intestine. Gastroenterology 92:1944–1950, 1987
Allen JM, Bloom SR: Effects of peptide YY and neuropeptide Y on gastric emptying in man. Digestion 30:255–262, 1984
Junien JL, Gue M, Bueno L: Neuropeptide Y and sigma ligand (JO1784) act throught a GI protein to block the corticotropin-releasing factor-induced colonic motor activation in rats. Neuropharmacology 30:1119–1124, 1991
Wahlestedt C, Yanaihara N, Håkanson R: Evidence for different pre- and post-junctional receptors for neuropeptide Y and related peptides. Regul Pept 13:307–318, 1986
Wiley J, Owyang C: Neuropeptide Y inhibits cholinergic transmission in the isolated guinea pig colon: Mediation through alpha-adrenergic receptor. Proc Natl Acad Sci USA 84:2047–2051, 1987
Furness JB, Costa M, Keast JR: Choline acetyltransferase and peptide immunoreactivity of submucous neurons in the small intestine of the guinea-pig. Cell Tissue Res 237:329–336, 1984
Decktor DL, Pendleton RG, Elnitsky AT, Jenkins AM, McDowell AP: Effect of metoclopramide, bethanechol and the cholecystokinin receptor antagonist, L-364, 718, on gastric emptying in the rat. Eur J Pharmacol 147:313–316, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matsuda, M., Aono, M., Moriga, M. et al. Centrally administered neuropeptide Y (NPY) inhibits gastric emptying and intestinal transit in the rat. Digest Dis Sci 38, 845–850 (1993). https://doi.org/10.1007/BF01295910
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01295910